APOE and Alzheimer disease: BrainAGE changing rates differed significantly between NO and sMCI subjects as compared to pMCI and AD subjects as well as between APOE ε4 carriers and non-carriers (p < 0.05; Fig 4), with ε4 carriers showing increased changing rates as compared to non-carriers (Table 1).